Skip to content

VenUS II: larval therapy Venous Ulcer Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN55114812
Enrollment
370
Registered
2004-06-18
Start date
2003-09-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous and mixed aetiology leg ulcers Circulatory System Venous ulcers

Interventions

3 armed trial: Larval therapy (loose and bagged) and Purilon hydrogel

Sponsors

University of York (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adults over 18 years old with leg uclers containing slough and/or necrotic tissue

Exclusion criteria

Exclusion criteria: Does not comply with inclusion criteria

Design outcomes

Primary

MeasureTime frame
Added 10/07/08: Time to healing of reference ulcer

Secondary

MeasureTime frame
Added 10/07/08: 1. Time to debridement of reference ulcer 2. Health related quality of life 3. Bacterial load (including MRSA) 4. Adverse event data 5. Costs of leg ulcer treatments

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 3, 2026